SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

27 Sep 2019 07:00

RNS Number : 8779N
Numis Corporation PLC
27 September 2019
 

Numis Corporation Plc ("Numis")

Trading Update

 

Embargoed for release 7.00 am, 27 September 2019

 

 

Friday 27 September 2019 at 7.00am: Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the year ending 30 September 2019.

 

The political uncertainty and challenging market conditions which impacted our first half performance have persisted throughout the second half of the financial year. UK equity capital markets volumes and trading activity in UK equities have both declined significantly compared to the prior year. Against this unfavourable market backdrop, Numis expects to report a reasonable second half performance delivering revenues in line with the first half and slightly behind the comparable period. This will result in reported revenues for the full year showing a mid to high teens percentage decline compared to the prior year, and a somewhat greater fall in profit given the operational gearing inherent in the business.

 

Investment Banking revenues have been impacted by lower deal volumes, particularly at the larger end of the transaction size range. Challenging market conditions often present opportunities to expand our corporate client base and we continue to add high quality companies to our list. We currently have 217 corporate clients, up from 210 at the start of the year.

 

Whilst public market deal flow has been subdued we have made good progress growing our private markets presence, including raising $460m for Swedish fintech business Klarna at a valuation of $5.5bn. The increase in revenue attributable to private markets transactions has partially offset the significant decline in UK listed capital markets activities. We will continue to target the revenue opportunities generated by the growing allocation of institutional capital to private markets activity.

 

Equities has reported an improved second half performance predominantly due to a better trading book performance. Execution revenues and research payments have remained consistent with the levels achieved in the first half, which suggests we have gained market share against a market which contracted over the period.

 

Our headcount is broadly flat compared to the prior year-end as we responded to the prevailing market uncertainty by focusing on efficiency and productivity gains, however, our longer term growth plans and strategy remain unchanged. We are pleased to confirm we have entered into a lease for new office space given the upcoming expiry of our current lease. We intend to relocate during the second half of FY21 and expect the new office will give rise to an increase of approximately £3m to our ongoing property costs, including the impact of IFRS 16, commencing FY21.

 

Numis will announce preliminary results for the year ending 30 September 2019 on Wednesday 4 December 2019.

 

 

Alex Ham and Ross Mitchinson, Co-Chief Executive Officers said:

 

"2019 was a challenging year, characterised by market share gains but depressed activity levels across both Investment Banking and Equities. The office move is indicative of our long term ambitions for the business. Over the past 13 years in our existing office we have doubled headcount, doubled the corporate client list and seen the average market capitalisation of that client base increase by a multiple of five. Whilst prevailing market conditions are difficult, we have a very strong balance sheet and exceptional people serving an enviable list of retained corporate clients and high quality institutions. We are well positioned to continue to capture greater market share and we will continue to focus on executing our long term strategy to build a more diversified investment banking business."

 

 

27 September 2019

 

END

 

 

Contacts

Numis

Alex Ham and Ross Mitchinson, Co-CEOs 020 7260 1245

Andrew Holloway, CFO 020 7260 1266

 

Brunswick (Public Relations Adviser):

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):

Philip Secrett 020 7728 2578

Jen Clarke 020 7865 2411Harrison J Clarke 020 7184 4384

 

 

Notes for Editors

 

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNVRRKSAKUUR
Date   Source Headline
28th Mar 20223:59 pmRNSTransaction in Own Shares & Total Voting Rights
24th Mar 20223:48 pmRNSTransaction in Own Shares & Total Voting Rights
22nd Mar 20224:09 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20223:43 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 202210:18 amRNSNotification of Major Holdings
17th Mar 20229:31 amRNSTransaction in Own Shares & Total Voting Rights
11th Mar 20223:36 pmRNSTransaction in Own Shares & Total Voting Rights
7th Mar 20224:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th Feb 20225:02 pmRNSTransaction in Own Shares & Total Voting Rights
24th Feb 20227:00 amRNSBoard Change – Appointment of Independent NED
22nd Feb 20222:35 pmRNSTransaction in Own Shares & Total Voting Rights
10th Feb 202210:03 amRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20221:13 pmRNSBoard Change
8th Feb 20221:12 pmRNS2022 Annual General Meeting ('AGM')
8th Feb 20227:00 amRNSAGM Trading Statement
7th Feb 20229:39 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20224:14 pmRNSHolding(s) in Company
1st Feb 20224:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20224:00 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20221:00 pmRNSDirectors’ Dealing
19th Jan 20227:00 amRNSGrant of awards under 2021 LTIP
14th Jan 20223:53 pmRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20224:27 pmRNSTransaction in Own Shares and Total Voting RIghts
5th Jan 20227:00 amRNSAppointment of General Counsel & Company Secretary
4th Jan 20223:21 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20214:53 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20214:33 pmRNSTransaction in Own Shares and Total Voting Rights
21st Dec 20215:04 pmRNSTransaction in Own Shares and Total Voting Rights
20th Dec 20212:30 pmRNSAnnual Report and AGM Notice
20th Dec 202112:29 pmRNSReplacement Director's Dealing
20th Dec 202112:09 pmRNSHolding(s) in Company
17th Dec 202112:31 pmRNSDirector’s Dealing
15th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSFull Year Results for the year ended 30 Sep 2021
29th Nov 20214:58 pmRNSNotice of Final Results for the year ended 30 Sep
18th Nov 20214:03 pmRNSHolding(s) in Company
30th Sep 202112:32 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSTrading Update
17th Sep 20214:25 pmRNSTR-1: Notification of major holdings
13th Sep 20216:29 pmRNSTR-1: Notification of major holdings
13th Sep 20216:27 pmRNSTR-1: Notification of major holdings
13th Sep 202112:54 pmRNSTR-1: Notification of major holdings
13th Sep 202112:50 pmRNSTR-1: Notification of major holdings
1st Sep 20217:00 amRNSChange of Registered Office
10th Aug 20217:00 amRNSBoard Change
29th Jul 20216:07 pmRNSTR-1: Notification of major holdings
14th Jul 20217:00 amRNSTrading Update
14th May 20217:00 amEQSEdison Investment Research Limited: Numis Corporation (NUM): Very strong results, consistent strategy
7th May 20217:00 amRNSHalf Year Results
23rd Apr 20214:24 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.